FY2024 EPS Estimates for Syra Health Increased by Analyst

Syra Health Corp. (NASDAQ:SYRA) – Analysts at Zacks Small Cap raised their FY2024 earnings per share estimates for Syra Health in a research report issued on Wednesday, October 30th. Zacks Small Cap analyst M. Marin now expects that the company will earn ($0.53) per share for the year, up from their prior forecast of ($0.86). The consensus estimate for Syra Health’s current full-year earnings is ($0.86) per share. Zacks Small Cap also issued estimates for Syra Health’s Q4 2024 earnings at ($0.07) EPS.

Syra Health Trading Down 2.4 %

NASDAQ:SYRA opened at $0.42 on Monday. Syra Health has a 12-month low of $0.34 and a 12-month high of $8.37. The firm has a market cap of $2.42 million and a PE ratio of -0.65. The stock has a fifty day moving average price of $0.55 and a 200 day moving average price of $1.07.

Syra Health (NASDAQ:SYRA) last released its earnings results on Tuesday, October 29th. The company reported ($0.06) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.21) by $0.15. The company had revenue of $2.25 million for the quarter, compared to analyst estimates of $1.99 million. Syra Health had a negative net margin of 54.90% and a negative return on equity of 131.94%. During the same period in the prior year, the business earned ($0.08) EPS.

About Syra Health

Syra Health Corp., a healthcare services company, provides health education, population health management, behavioral and mental health, healthcare workforce, and digital health services in the United States. It offers health education services, including medical communications, patient education, and healthcare training; and population health management services, such as analytics as a service, epidemiology, and health equity analytics solutions.